Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

MULTIPLE ELECTROLYT

Active
SPE2DP-26-T-4243Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract specifies the procurement of Multiple Electrolytes Injection, Type 1, USP, in 500 mL bags, packaged in units of 24 per package, with a required shelf life of 18 months. No more than three months may have elapsed between the date of manufacture and the date of delivery to the government. The product is regulated by the FDA and must meet all applicable technical and quality requirements as defined in the DLA Master List of Technical and Quality Requirements, with packaging and marking strictly compliant with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Each unit must be sealed in a suitable container to prevent damage, and shipping containers must ensure safe, low-cost delivery to the point of delivery at Fort Bliss, Texas, with inspection and acceptance occurring at the destination. The item is identified by NSN 6505-01-462-5414 and manufacturer part number NDC00338-0221-03, produced by Baxter Healthcare Corp. The contract requires delivery within 20 days under FOB destination terms with zero variance allowed in quantity. The solicitation is issued under SPE2DP-26-T-4243 with a response deadline in July 2026, and the unit of issue is PG (package of 24), aligned to the DoD authorized unit. Additional provisions include handling of covered defense information and compliance with DLA’s packaging and labeling standards for medical acquisitions.

General Info

Baxter Healthcare to supply 500 mL Electrolytes Injection, 24 per package, NSN 6505-01-462-5414, FOB Fort Bliss, delivery in 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

21287 LIGHT INFANTRY AVENUE, FORT BLISS, TX, 79918-2527, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-4243.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseSolicitation
Posted

Solicitation

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUS
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUS

Full Description

Show more
MULTIPLE ELECTROLYT
MULTIPLE ELECTROLYTES INJECTION, TYPE 1,USP<(>,<)>
MULTIPLE ELECTROLYTES INJECTION TYPE 1 USP,PH 7.4<(>,<)>
500 ML, BAG,24'S
UNIT OF ISSUE PG(PACKAGE OF 24)
..
SHALL HAVE A SHELF LIFE OF 18 MONTHS.
NOT MORE THAN 3 MONTHS SHALL HAVE ELAPSED FROM
DATE OF MANUFACTURE TO DATE OF DELIVERY TO THE
GOVERNMENT.
.
MARK IN ACCORDANCE WITH MMS No. 1B 30 March 2017 .. RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. 1 PG = 24 EA
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED IN A SUITABLE SEALED UNIT CONTAINER CAPABLE OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT THE LOWEST RATE, TO POINT OF DELIVERY CALLED FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1 (MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA TROOP SUPPORT VIA EMAIL TO fssb@dla.mil.
SPE2DP-26-T-4243
SECTION B
MMS NO. 1 IS ALSO AVAILABLE ONLINE AT:
https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
RS012: Shelf-life requirement RS001 for a TYPE I (CODE J) item with a shelf life of 15 months (non-extendable) applies to this item.
BAXTER HEALTHCARE CORP IV 04687 P/N 2B2543Q BAXTER HEALTHCARE CORP IV 04687 P/N NDC00338-0221-03
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7017578692 0001 PG 1.000
NSN/MATERIAL:6505014625414
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-462-5414 Quantity: 1 PG Purchase Request: 7017578693QTY: 1 Delivery: 20 days ADO

Similar Contracts

Same NAICS industry code

NAICS: 325412
New
DIBBS
FLUCONAZOLE TABLETSFluconazole Tablets 150 mg are supplied in individually sealed blister strips containing 12 tablets per strip, with the unit of issue defined as a package. The product must have a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Packaging must comply with commercial standards and be designed to protect the contents from damage or breakage, with exterior shipping containers suitable for safe transport at the lowest possible freight rate. All items must be marked in accordance with Medical Marking Standard No. 1, which supersedes MIL-STD-129, and mercury or mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the supply except under specific exceptions for functional components like batteries or instruments, which must meet additional containment and shockproof requirements. The National Stock Number is 6505013953039, and the contract is issued under solicitation SPE2DP-26-T-4241 with delivery required FOB destination within 20 days. The quantity ordered is one package with zero variance allowed, and inspection and acceptance occur at the delivery point. The manufacturer identified is Golden State Medical Supply, Inc. with NDC 51407-0426-12, and ANIP Acquisition Co with NDC 62559-0992-12. Applicable technical and quality requirements are referenced from the DLA Master List, and the contract falls under the NAICS code 325412 for pharmaceutical manufacturing.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details
NAICS: 325412
New
DIBBS
DIBUCAINE OINTMENTDIBUCAINE OINTMENT USP, containing 1 percent dibucaine as the active ingredient, is supplied in a collapsible tube with a rectal applicator and is intended for rectal administration only, classified for external use. Each unit of issue is a single package containing one ounce or 28 grams of the ointment, with a non-extendable shelf life of 36 months and storage requirements between 15 and 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is FDA-regulated and must comply with the DLA Master List of Technical and Quality Requirements, including MIL-STD-129 for marking and labeling, and packaging must adhere to RP001 for DLA procurement standards, with materials either packaged per IP025 if hazardous or ASTM D3951 if not, prioritizing DLA specifications over commercial standards. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, with a unit of issue in packages and quantity per unit pack of one. The contract SPE2DP-26-T-4234 specifies four separate line items totaling 11 packages, each priced at $2.00, with delivery due within 20 days of order, FOB destination, zero quantity variance allowed, and inspection and acceptance occurring at the delivery point. Shipments are directed to four distinct U.S. Navy vessel addresses in FPO locations, with explicit instructions to avoid parcel post and use only traceable freight methods via VSM. Required delivery dates span from May 29, 2026, to July 24, 2026, with specific RDD codes and project identifiers linked to each delivery. The product must be procured from the HARVARD DRUG GROUP, L.L.C., and all packaging, labeling, and shipping must strictly follow DLA technical and quality directives, including medical marking standards and palletization requirements, ensuring full compliance with federal procurement protocols.
MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 20 hours ago

DEADLINE

in 5 days
View Details